PRO29 COST-EFFECTIVENESS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE IN A DANISH SETTING
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2359
https://www.valueinhealthjournal.com/article/S1098-3015(19)34737-0/fulltext
Title :
PRO29 COST-EFFECTIVENESS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE IN A DANISH SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34737-0&doi=10.1016/j.jval.2019.09.2359
First page :
Section Title :
Open access? :
No
Section Order :
12062